Overview
Manish Balwani practices in Wardha, India. Mr. Balwani is highly rated in 15 conditions, according to our data. His top areas of expertise are Glomerulonephritis, Atypical Hemolytic Uremic Syndrome (aHUS), Hemolytic-Uremic Syndrome, Kidney Transplant, and Nephrectomy.
His clinical research consists of co-authoring 63 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- ABO IncompatibilityMr. Balwani isAdvanced. Learn about ABO Incompatibility.
- AnemiaMr. Balwani isAdvanced. Learn about Anemia.
- Atypical Hemolytic Uremic Syndrome (aHUS)
- Carpenter SyndromeMr. Balwani isAdvanced. Learn about Carpenter Syndrome.
- D-Minus Hemolytic Uremic SyndromeMr. Balwani isAdvanced. Learn about D-Minus Hemolytic Uremic Syndrome.
- D-Plus Hemolytic Uremic SyndromeMr. Balwani isAdvanced. Learn about D-Plus Hemolytic Uremic Syndrome.
- Experienced
- Acute Tubular NecrosisMr. Balwani isExperienced. Learn about Acute Tubular Necrosis.
- Alport SyndromeMr. Balwani isExperienced. Learn about Alport Syndrome.
- BrachydactylyMr. Balwani isExperienced. Learn about Brachydactyly.
- CalcinosisMr. Balwani isExperienced. Learn about Calcinosis.
- Chronic Kidney DiseaseMr. Balwani isExperienced. Learn about Chronic Kidney Disease.
- COVID-19Mr. Balwani isExperienced. Learn about COVID-19.